DRMA
Price
$0.71
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Capitalization
4.49M
PVLA
Price
$23.49
Change
-$0.32 (-1.34%)
Updated
Jun 5 closing price
Capitalization
259.7M
Interact to see
Advertisement

DRMA vs PVLA

Header iconDRMA vs PVLA Comparison
Open Charts DRMA vs PVLABanner chart's image
Dermata Therapeutics
Price$0.71
Change-$0.00 (-0.00%)
Volume$2.25K
Capitalization4.49M
Palvella Therapeutics
Price$23.49
Change-$0.32 (-1.34%)
Volume$48.2K
Capitalization259.7M
DRMA vs PVLA Comparison Chart
Loading...
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRMA vs. PVLA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRMA is a Hold and PVLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (DRMA: $0.70 vs. PVLA: $23.49)
Brand notoriety: DRMA and PVLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRMA: 87% vs. PVLA: 62%
Market capitalization -- DRMA: $4.49M vs. PVLA: $259.7M
DRMA [@Biotechnology] is valued at $4.49M. PVLA’s [@Biotechnology] market capitalization is $259.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRMA’s FA Score shows that 1 FA rating(s) are green whilePVLA’s FA Score has 1 green FA rating(s).

  • DRMA’s FA Score: 1 green, 4 red.
  • PVLA’s FA Score: 1 green, 4 red.
According to our system of comparison, PVLA is a better buy in the long-term than DRMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRMA’s TA Score shows that 3 TA indicator(s) are bullish while PVLA’s TA Score has 3 bullish TA indicator(s).

  • DRMA’s TA Score: 3 bullish, 5 bearish.
  • PVLA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both DRMA and PVLA are a bad buy in the short-term.

Price Growth

DRMA (@Biotechnology) experienced а -3.83% price change this week, while PVLA (@Biotechnology) price change was -5.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

DRMA is expected to report earnings on Mar 17, 2025.

PVLA is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($260M) has a higher market cap than DRMA($4.49M). PVLA YTD gains are higher at: 95.750 vs. DRMA (-47.852).
DRMAPVLADRMA / PVLA
Capitalization4.49M260M2%
EBITDA-11.53MN/A-
Gain YTD-47.85295.750-50%
P/E RatioN/A14.22-
Revenue0N/A-
Total Cash6.14MN/A-
Total Debt175KN/A-
FUNDAMENTALS RATINGS
PVLA: Fundamental Ratings
PVLA
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRMAPVLA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JINTX33.28N/A
N/A
Johnson International
RYPCX6.60N/A
N/A
Royce Small-Cap Fund Consult
HSCYX28.02N/A
N/A
Hartford Small Company Y
FATEX107.19N/A
N/A
Fidelity Advisor Technology M
MOWNX18.52N/A
N/A
Moerus Worldwide Value N

DRMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRMA has been loosely correlated with IRON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DRMA jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRMA
1D Price
Change %
DRMA100%
-0.56%
IRON - DRMA
43%
Loosely correlated
+1.39%
PVLA - DRMA
36%
Loosely correlated
-1.34%
KANT - DRMA
28%
Poorly correlated
-1.81%
KRRO - DRMA
28%
Poorly correlated
+3.96%
AVXL - DRMA
27%
Poorly correlated
+0.65%
More

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with DRMA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then DRMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
-1.34%
DRMA - PVLA
36%
Loosely correlated
-0.56%
DSGN - PVLA
30%
Poorly correlated
-2.44%
KPRX - PVLA
26%
Poorly correlated
-3.13%
IKNA - PVLA
25%
Poorly correlated
-2.61%
PTGX - PVLA
25%
Poorly correlated
+4.44%
More